Market research
002750.SHE Kunming Longjin Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 236M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.21
Community
Investor discussion
1 comment
Sign in to join the 002750.SHE discussion.
5 years, 5 months ago
Kunming Longjin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.
From a valuation standpoint, the stock is 33.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.9.
Kunming Longjin Pharmaceutical Co., Ltd's total revenue rose by 11.9% to $64M since the same quarter in the previous year.
Its net income has increased by 735.4% to $4M since the same quarter in the previous year.
Finally, its free cash flow fell by 153.6% to $-5M since the same quarter in the previous year.
Based on the above factors, Kunming Longjin Pharmaceutical Co., Ltd gets an overall score of 2/5.